Papillary Renal Cell Carcinoma

What Papillary Renal Cell Carcinoma Means

Papillary renal cell carcinoma (PRCC) is a type of kidney cancer that starts in the lining of tiny tubes inside the kidney. These tubes are important because they filter blood, returning substances the body needs and removing waste and extra fluid as urine. The name “papillary” comes from how the tumor cells look under a microscope—they often form long, thin, finger-like shapes.

There are two main types of PRCC: type 1 and type 2. Type 1 usually grows more slowly and is less likely to spread to other parts of the body. Type 2 can be more aggressive and may spread more quickly. Understanding which type a person has can help doctors decide on the best treatment and follow-up care.

Why It Matters in Cancer Care

Knowing that a kidney tumor is papillary renal cell carcinoma helps doctors understand how the cancer might behave. Because type 1 and type 2 PRCC can act differently, identifying the type can guide treatment choices and monitoring plans. Some people have inherited genetic conditions that increase their risk of developing PRCC. For example, hereditary papillary renal cancer is linked to type 1 PRCC, while hereditary leiomyomatosis and renal cell cancer (HLRCC) is linked to type 2. These inherited risks may lead doctors to recommend genetic counseling and testing for patients and their family members.

What Patients Might See or Hear

If you or a loved one is diagnosed with PRCC, you might hear the terms papillary kidney cancer or PRCC. Your doctor may explain the difference between type 1 and type 2 tumors and discuss whether genetic testing is recommended. You might see these terms in pathology reports, treatment plans, or genetic counseling sessions. It’s important to ask your care team what the tumor type means for your treatment and follow-up.

How Doctors Use This Information

Doctors use the diagnosis of PRCC to help stage the cancer, which means determining how far it has grown or spread. This information helps guide treatment decisions, such as whether surgery is needed or if other therapies might be recommended. Knowing the tumor type also helps plan follow-up care to watch for any signs of the cancer returning or spreading.

Related Terms and Genetic Links

PRCC is related to other types of kidney cancer but specifically refers to tumors with papillary features. It is also connected to hereditary cancer syndromes. For example, hereditary papillary renal cancer (HPRC) is an inherited condition linked to type 1 PRCC and involves mutations in the MET gene. Hereditary leiomyomatosis and renal cell cancer (HLRCC) is linked to type 2 PRCC and involves mutations in the fumarate hydratase (FH) gene. These genetic connections are important for understanding risk and guiding family testing.

What PRCC Does Not Automatically Mean

Having a diagnosis of papillary renal cell carcinoma does not automatically mean the cancer will behave aggressively or that the outcome will be poor. The tumor type, stage, and other factors all influence prognosis and treatment options. Also, seeing terms like hereditary papillary renal cancer or FH gene mutations in medical reports does not mean a person definitely has cancer—it may indicate a genetic risk that requires further evaluation.

Next Steps and Safety

This information is meant to help you understand what papillary renal cell carcinoma is and why it might be mentioned in your care. It does not replace personalized medical advice. Each person’s situation is unique, and treatment plans depend on many factors beyond the cancer type alone. If you or a loved one has been diagnosed with PRCC, the best next step is to discuss the diagnosis and treatment options in detail with your healthcare provider. They can explain what the findings mean for your care and help you understand your options moving forward.